Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-03-29
2011-03-29
Szperka, Michael (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S133100, C424S139100, C424S178100, C530S387900, C530S388220
Reexamination Certificate
active
07914789
ABSTRACT:
The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.
REFERENCES:
patent: 6207642 (2001-03-01), Wiley
patent: 6531447 (2003-03-01), Ruben et al.
patent: 6727225 (2004-04-01), Wiley
patent: 6824773 (2004-11-01), Wiley
patent: 7001992 (2006-02-01), Ruben et al.
patent: 7169387 (2007-01-01), Rennert
patent: 7208151 (2007-04-01), Browning et al.
patent: 7368531 (2008-05-01), Rosen et al.
patent: 2004/0253610 (2004-12-01), Wiley
patent: 2005/0054047 (2005-03-01), Wiley
patent: 2005/0208046 (2005-09-01), Kim et al.
patent: 2006/0025574 (2006-02-01), Ruben et al.
patent: 2006/0084143 (2006-04-01), Wiley
patent: 2006/0147982 (2006-07-01), Ruben et al.
patent: 2007/0248593 (2007-10-01), Ruben et al.
patent: 2008/0004432 (2008-01-01), Ruben et al.
patent: 2008/0008714 (2008-01-01), Browning et al.
patent: WO 95/31544 (1995-11-01), None
patent: WO 97/18235 (1997-05-01), None
patent: WO 98/54206 (1998-12-01), None
patent: WO 98/55508 (1998-12-01), None
patent: WO 99/61471 (1999-12-01), None
patent: WO 01/45730 (2001-06-01), None
Stryer, L. Biochemistry, 4thedition, 1995, W. H. Freeman and Company, pp. 100-102.
Stedman's Medical Dictionary Online definitions of “isotope”, “isotype”, “radioisotope” and “radioisotype” downloaded Sep. 29, 2009, four pages.
U.S. Appl. No. 09/189,144, filed Nov. 10, 1998, Rubin et al.
U.S. Appl. No. 60/056,250, filed Aug. 29, 1997, Yu et al.
U.S. Appl. No. 60/056,293, filed Aug. 29, 1997, Yu et al.
U.S. Appl. No. 60/056,296, filed Aug. 29, 1997, Yu et al.
U.S. Appl. No. 60/044,039, filed May 30, 1997, Carter et al.
U.S. Appl. No. 60/048,093, filed May 30, 1997, Carter et al.
U.S. Appl. No. 60/048,101, filed May 30, 1997, Yu et al.
U.S. Appl. No. 60/048,190, filed May 30, 1997, Carter et al.
U.S. Appl. No. 60/048,356, filed May 30, 1997, Yu et al.
U.S. Appl. No. 60/050,935, filed May 30, 1997, Yu et al.
U.S. Appl. No. 12/324,825, filed Nov. 26, 2008, Ruben et al.
EP Examination Report dated Apr. 25, 2008 for EP 98926105.2.
EP Examination Report dated Jun. 12, 2007 for EP 98926105.2.
EP Examination Report dated Jun. 1, 2006 for EP 98926105.2.
EP Examination Report dated May 6, 2005 for EP 98926105.2.
European Search Report dated Apr. 2, 2004 for EP 98926105.2.
International Preliminary Examination Report dated Nov. 8, 1999 for PCT/U598/10868.
International Search Report mailed Oct. 28, 1998 for PCT/US98/10868.
Hillier et al., Genbank Accession No. N20562 (Dec. 18, 1995).
Hillier et al., Genbank Accession No. N23080 (Dec. 28, 1995).
Hillier et al., Genbank Accession No. H18098 (Jun. 29, 1995).
Hillier et al., Genbank Accession No. N46256 (Feb. 14, 1996).
Hillier et al., Genbank Accession No. N28611 (Jan. 4, 1996).
Hillier et al., Genbank Accession No. R70283 (Jun. 1, 1995).
Hillier et al., Genbank Accession No. T98012 (Mar. 29, 1995).
Hudson, Genbank Accession No. G23170 (May 31, 1996).
Genexpress, Genbank Accession No. Z44692 (Sep. 21, 1995).
Marra et al., Genbank Accession No. W83277 (Sep. 12, 1996).
Ricke et al., “Sequencing of human chromosome 16p13.3”,Datebase EMBL Human—Online!Homo sapienschromosome 16, cosmid clone 363E3, May 5, 1998.
Genbank Accession No. AI768116 (Dec. 20, 1999).
Hillier et al., Genbank Accession No. AA149044 (May 19, 1997).
Genbank Accession No. AW204761 (Dec. 2, 1999).
Genbank Accession No. AI768403 (Dec. 20, 1999).
Chen et al., Genbank Accession No. AA631934 (Oct. 20, 1997).
Genbank Accession No. AI221536 (Nov. 29, 1998).
Genbank Accession No. AW172990 (Nov. 16, 1999).
Genbank Accession No. AW051452 (Sep. 20, 1999).
Genbank Accession No. AW262030 (Dec. 28, 1999).
Genbank Accession No. AI219327 (Nov. 29, 1998).
Genbank Accession No. BF114971 (Oct. 24, 2000).
Genbank Accession No. AI800959 (Dec. 19, 1999).
Genbank Accession No. AI004154 (Aug. 27, 1998).
Hillier et al., Genbank Accession No. AA149043 (May 19, 1997).
Genbank Accession No. AW338518 (Jan. 31, 2000).
Genbank Accession No. AI568941 (May 14, 1999).
Hillier et al., Genbank Accession No. N41733 (Jan. 24, 1996).
Genbank Accession No. Al827127 (Mar. 7, 2000).
Lanfranchi et al., Genbank Accession No. F25336 (May 13, 1999).
Genbank Accession No. AI313436 (Feb. 3, 1999).
Genbank Accession No. AA994944 (Aug. 27, 1998).
Dias et al., Genbank Accession No. AW938942 (May 30, 2000).
Genbank Accession No. AI761510 (Dec. 21, 1999).
Genbank Accession No. BF063028 (Oct. 16, 2000).
Genbank Accession No. AW628237 (Mar. 31, 2000).
Hillier et al., Genbank Accession No. T56712 (Feb. 7, 1995).
Hillier et al., Genbank Accession No. AI718198 (Jun. 10, 1999).
Hillier et al., Genbank Accession No. R48167 (May 18, 1995).
Genbank Accession No. BF108787 (Oct. 20, 2000).
Genbank Accession No. BF197631 (Oct. 3, 2000).
Genbank Accession No. AI767239 (Dec. 21, 1999).
Genbank Accession No. AW001699 (Mar. 8, 2000).
Genbank Accession No. AI796303 (Dec. 20, 1999).
Genbank Accession No. AI358289 (Feb. 15, 1999).
Genbank Accession No. AW149867 (Nov. 3, 1999).
Genbank Accession No. AA576558 (Sep. 9, 1997).
Genbank Accession No. AI911799 (Dec. 17, 1999).
Genbank Accession No. AA610401 (Dec. 9, 1997).
Liew, Genbank Accession No. N83862 (Apr. 1, 1996).
Genbank Accession No. AI470703 (Apr. 13, 1999).
Genbank Accession No. BG236779 (Feb. 12, 2001).
Genbank Accession No. AI470484 (Apr. 13, 1999).
Genbank Accession No. AI492143 (Mar. 30, 1999).
Hillier et al., Genbank Accession No. T74424 (Mar. 2, 1995).
Genbank Accession No. AW166567 (Nov. 12, 1999).
Genbank Accession No. AI864228 (Aug. 30, 1999).
Genbank Accession No. Al813825 (Mar. 7, 2000).
Genbank Accession No. AI086734 (Oct. 1, 1998).
Genbank Accession No. AI270718 (Dec. 2, 1998).
Genbank Accession No. AI401800 (Mar. 30, 1999).
Genbank Accession No. AI799902 (Dec. 17, 1999).
Hillier et al., Genbank Accession No. H95227 (Nov. 25, 1996).
Genbank Accession No. AI264959 (Nov. 13, 1998).
Genbank Accession No. AI611273 (May 14, 1999).
Genbank Accession No. AI867518 (Dec. 17, 1999).
Genbank Accession No. AA873480 (Apr. 29, 1998).
Genbank Accession No. AA970894 (Jul. 7, 1998).
Adams et al., Genbank Accession No. AA386018 (Apr. 21, 1997).
Genbank Accession No. AI910684 (Jul. 28, 1999).
Genbank Accession No. AI858303 (Mar. 7, 2000).
Genbank Accession No. AI701259 (Dec. 17, 1999).
Genbank Accession No. AI189491 (Oct. 28, 1998).
Genbank Accession No. AW988312 (Jun. 2, 2000).
Hillier et al., Genbank Accession No. T74049 (Mar. 2, 1995).
Genbank Accession No. BE042437 (Jun. 8, 2000).
Charnock-Jones et al., “Extension of incomplete cDNAs (ESTs) by biotin/streptavidin-mediated walking using the polymerase chain reaction”, J. of Biotechnology, 35:205-215 (1994).
Colman, “Effects of amino acid sequence changes on antibody-antigen interactions,” Research in Immunology, 145:33-36 (1994).
Feng et al., “The Fn14 Immediate-Early Response Gene Is Induced During Liver Regeneration and Highly Expressed in Both Human and Murine Hepatocellular Carcinomas”, Am.J.of Pathol., 156(4): 1253-1261 (2000).
Janeway et al., Immunobiology, third edition, 1996, pp. 1:6, 2:2, 2:17, 2:18, 3:2-3:5, and 3:9.
Meighan-Mantha et al., “The Mitogen-indicible Fn14 Gene Encodes a Type I Transmembrane Protein that Modulated Fibroblast Adhesion and Migration”, J. Of Biol. Chem., 274(46): 33166-33176 (Nov. 12, 1999).
Skolnick et al., “From genes to protein structure and function,” Trends in Biotechnology, 18:34-39, (2000).
Whisstock et al., “Prediction of protein function from protein sequence and structure”, Quarterly Reviews of Biophysics, 36:307-340 (2003).
U.S. Appl. No. 09/690,454, Office Action mailed Jan. 17, 2002.
U.S. Appl. No. 09/690,454, Office Action mailed Apr. 26, 2002.
U.S. Appl
Endress Gregory A.
Rosen Craig A.
Ruben Steven M.
Facet Biotech Corporation
Szperka Michael
Townsend and Townsend / and Crew LLP
LandOfFree
HEMCM42 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HEMCM42 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HEMCM42 antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2632060